“Interchangeability of Selarsdi with Stelara will further enable increased access for US patients to more affordable treatment options and contribute to lowering health care costs, which is an ...

A report from the inspector general of HHS examines the latest trends since several biosimilar versions of Humira were ...

Since September, Dr Savoy has been active as an independent consultant, advising clients in biosimilar and biobetter drug developments ... at Roche involved the design and implementation of ...

Juliana Reed - Biosimilars Forum "In order for biosimilars to offer cost-savings of up to 85% discounts on reference product medicines, the industry has had to design and implement one of the most ...

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and ...

Incentivizing physicians with modest financial bonuses may seem like a small step, but in Japan’s outpatient oncology setting ...

Sales of the company’s copycat to J&J’s blockbuster reached $150 million in the first quarter, adding to a surge in revenue ...

Holz, MD, discussed the approval and benefits of the ustekinumab biosimilar, Yesintek, emphasizing its comparable efficacy and safety to Stelara, and potential for increased patient access due to ...

Historically, doctors have been a whole lot more comfortable writing a new prescription for a biosimilar than they have been switching a patient that's on an established drug. We need to do more ...

Nplate contains the active ingredient romiplostim, and it’s available only as a brand-name biologic drug. It doesn’t come in a biosimilar version. A biosimilar medication is a drug that’s ...

Carvykti contains the active ingredient ciltacabtagene autoleucel, and it’s available only as a brand-name biologic drug. It doesn’t come in a biosimilar version. A biosimilar medication is a ...